Drug Candidate Name
Drug Candidate Description

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Company Name
Company Information
GET IN TOUCH

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Drug Candidates
Therapeutic AreaNeurology
IndicationNeurological disorders
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
Therapeutic AreaDermatology
IndicationWounds and injuries
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
Therapeutic AreaImmuno-Oncology
IndicationImmunological disorders
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
Therapeutic AreaGastroenterology
IndicationInflammatory bowel diseases
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
Therapeutic AreaOphthalmology
IndicationDry eyes
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
Therapeutic AreaCardiovascular Diseases
IndicationCardiovascular disorders
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
Therapeutic AreaDiabetis and Endocrinology
IndicationType 2 diabetes mellitus
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
Drug Class
Amino acids peptides and proteinsAnti-inflammatoriesBiological proteinsChemoprotectantsCytoprotectivesEye disorder therapiesImmunotherapiesIrritable bowel syndrome therapiesRadioprotectivesSkin disorder therapiesSunscreensSurfactants
Mechanism of Action
Cell modulators, Enzyme modulators, Haemic and immune system modulators, Immunologic cytotoxicity, Metabolism-modulators, Signal transduction pathway modulators, NF-kappa B modulators
New Molecular Entity
Shelved
Attachments and Links
Non-Confidential Information
Drug candidate and company presentations; links to publications, clinical trials, press releases, videos and medias